Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell

H Bouterfa1, T Picht, D Kess

  • 1Department of Neurosurgery, University of Würzburg, Germany.

Neurosurgery
|February 26, 2000
PubMed
Abstract

Insights

Retinoids significantly inhibit proliferation and migration in primary glioblastoma cultures, suggesting potential for treating malignant gliomas. Most established cell lines showed no sensitivity to retinoic acid (RA).

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Retinoids, vitamin A derivatives, possess known anti-cancer properties, including differentiation induction and growth inhibition.
  • Limited data exists on retinoid efficacy in glial tumors, necessitating further investigation.

Purpose of the Study:

  • To investigate the effects of natural retinoic acid (RA) forms on glioma cell lines and primary glioblastoma cultures.
  • To assess retinoid impact on proliferation, migration, and invasion.

Main Methods:

  • Utilized six human and one rat glioma cell lines, plus 20 primary glioblastoma cultures.
  • Assessed proliferation, migration (video-morphometry), and invasion (coculture system).
  • Determined retinoid receptor (RAR, RXR) expression via RT-PCR.

Main Results:

  • Retinoids inhibited proliferation (30-95%) and migration (24-65%) in primary glioblastoma cultures but not most cell lines.
  • Invasion remained unaffected by retinoid treatment.
  • Primary cultures showed consistent RAR gamma and RXR alpha expression, unlike cell lines.

Conclusions:

  • Retinoids demonstrate potent anti-proliferative and anti-migratory effects on primary human glioblastomas.
  • Findings support clinical trials of retinoids for malignant glioma treatment.
  • Discrepancies in retinoid sensitivity between cell lines and primary cultures warrant further study.